These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 6482814)

  • 1. Effect of 1-hexadecyl-2-acetyl-sn-glycero-3-phosphorylcholine on blood pressure by intra-lateral ventricular injection in the rat.
    Saeki S; Masugi F; Ogihara T; Otsuka A; Koyama Y; Nagano M; Kumagai A; Kumahara Y
    Med J Osaka Univ; 1984 Mar; 34(3-4):57-60. PubMed ID: 6482814
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypotensive activity of 1-O-hexadecyl-2-O-acetyl-sn-glycero-3-phosphocholine in rats with various types of hypertension.
    Saeki S; Ogihara T; Masugi F; Otsuka A; Koyama Y; Kumahara Y
    Med J Osaka Univ; 1983 Sep; 34(1-2):17-20. PubMed ID: 6669136
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the interactions of acetyl glycerol ether phosphoryl choline with the sympathetic nervous system in rats.
    Sybertz EJ; Sabin C; Baum T; Eynon E; Nelson S; Moran R
    J Pharmacol Exp Ther; 1982 Dec; 223(3):594-8. PubMed ID: 7143227
    [No Abstract]   [Full Text] [Related]  

  • 4. alpha-Adrenergic blocking action of 1-O-hexadecyl-2-O-acetyl-sn-glycero-3-phosphocholine in rats.
    Otsuka A; Masugi F; Ogihara T; Saeki S; Koyama Y; Kumahara Y
    Clin Exp Hypertens A; 1983; 5(4):625-35. PubMed ID: 6133661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 1-alkyl-2-acetyl-sn-glycero-3-phosphorylcholine inhibitor on the reduction of one-kidney, one clip hypertension after unclipping in the rat.
    Masugi F; Ogihara T; Otsuka A; Saeki S; Kumahara Y
    Life Sci; 1984 Jan; 34(2):197-201. PubMed ID: 6694519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural features of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) required for hypotensive and platelet serotonin responses.
    Blank ML; Cress EA; Lee TC; Malone B; Surles JR; Piantadosi C; Hajdu J; Snyder F
    Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):3-20. PubMed ID: 7146619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypotensive and vasodilatory activity of (+/-) 1-o-octadecyl-2-acetyl glyceryl-3-phosphorylcholine in the normotensive rat.
    Lai FM; Shepherd CA; Cervoni P; Wissner A
    Life Sci; 1983 Mar; 32(10):1159-66. PubMed ID: 6338331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of platelet activating factor on isolated rat hearts.
    Pugsley MK; Salari H; Beatch GN; Walker MJ
    Proc West Pharmacol Soc; 1990; 33():129-32. PubMed ID: 2274523
    [No Abstract]   [Full Text] [Related]  

  • 9. Antihypertensive effects of I-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine on plasma renin activity and catecholamine responses in spontaneously hypertensive rats.
    Hubbard JW; Cox RH; Lawler JE; Blank ML; Snyder F
    Life Sci; 1983 Jan; 32(3):221-32. PubMed ID: 6337313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of antihypertensive polar renomedullary lipid in the pathogenesis of hypertension.
    Masugi F; Ogihara T; Otsuka A; Saeki S; Kumahara Y
    Jpn Circ J; 1984 Feb; 48(2):196-200. PubMed ID: 6366289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent hypotensive activity of 1-O-hexadecyl-2-O-acetyl-SN-glycero-3-phosphocholine in spontaneously hypertensive rat.
    Masugi F; Ogihara T; Otsuka A; Saeki S; Kumahara Y
    Biochem Biophys Res Commun; 1982 Jan; 104(1):280-4. PubMed ID: 7041899
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet-activating factor and WEB-2086 directly modulate rat cardiomyocyte contractility.
    Delbridge LM; Stewart AG; Goulter CM; Morgan TO; Harris PJ
    J Mol Cell Cardiol; 1994 Feb; 26(2):185-93. PubMed ID: 8006979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Formation of a structural isomer of platelet activating factor during acetylation of 1-alkyl-sn-glycero-3-phosphocholine].
    Chupin VV; Ostapenko OV; Klykov VN; Anikin MV; Serebrennikova GA
    Bioorg Khim; 1993 Nov; 19(11):1111-21. PubMed ID: 8285924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactive amide of prostaglandin E1 and ethanolamine plasmalogen analog of platelet-activating factor inhibits several pathways of human platelet aggregation.
    Kulikov VI; Muzya GI
    Biochemistry (Mosc); 2000 Apr; 65(4):427-30. PubMed ID: 10810178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of the precursor (lyso-PAF) of platelet-activating factor via a CoA-dependent transacylase.
    Blank ML; Fitzgerald V; Smith ZL; Snyder F
    Biochem Biophys Res Commun; 1995 May; 210(3):1052-8. PubMed ID: 7763233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of sn-2-acetylated analogs of phosphatidalic acid on release and aggregation of human platelets].
    Muzia GI; Kulikov VI
    Biokhimiia; 1996 Mar; 61(3):455-60. PubMed ID: 8724603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro-erectile effect of systemic apomorphine: existence of a spinal site of action.
    Giuliano F; Allard J; Rampin O; Droupy S; Benoit G; Alexandre L; Bernabé J
    J Urol; 2002 Jan; 167(1):402-6. PubMed ID: 11743364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-enzymatic platelet-activating factor formation by acetylated proteins.
    Thanou PG; Tsoukatos DC
    FEBS Lett; 2004 Aug; 573(1-3):11-4. PubMed ID: 15327967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synthesis of 1-(1-alkenyl)-2-acetyl-sn-glycero-3-phosphocholines, the aldehyded analogs of platelet activating factor].
    Gordeev KIu; Serebrennikova GA; Evstigneeva RP
    Bioorg Khim; 1987 Jan; 13(1):109-12. PubMed ID: 3566815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory exudates in skin windows induced by 1-0-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine.
    Humphrey DM
    Am J Pathol; 1990 Feb; 136(2):467-77. PubMed ID: 2407127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.